Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

Presentation THT Abstracts 2025

The Diabetes Paradox: Outcomes in Heart Failure Patients With Diabetes

Presenter: Navneet Sandhu

February 11, 2025

Presentation THT Abstracts 2025

Impact of LV Unloading Strategy on Clinical Outcomes of Patients Supported With VA-ECMO from the Cardiogenic Shock Working Group

Presenter: Kevin John

February 11, 2025

Presentation THT Abstracts 2025

Trend and Impact of Right Heart Catheterization on Outcomes in Cardiogenic Shock

Presenter: Qianlan Xi

February 11, 2025

Presentation THT Abstracts 2025

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Presenter: Qianlan Xi

February 11, 2025

Presentation THT Abstracts 2025

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Presenter: Thitiphan Srikulmontri

February 11, 2025

Presentation THT Abstracts 2025

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Presenter: Neha Panigrahy

February 11, 2025

Presentation THT Abstracts 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT Abstracts 2025

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Presenter: Thitiphan Srikulmontri

February 11, 2025

Presentation THT Abstracts 2025

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Presenter: Ahmed Mahmoud

February 11, 2025

Presentation THT Abstracts 2025

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Presenter: Abduljabar Adi

February 11, 2025

Presentation THT Abstracts 2025

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Presenter: Emily Rodriguez

February 11, 2025

Presentation THT Abstracts 2025

Impact of Psychological Comorbidities on Clinical Outcomes in Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT Abstracts 2025

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Presenter: Aasim Afzal

February 11, 2025

Presentation THT Abstracts 2025

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Presenter: Tahira Qadeer

February 11, 2025

Presentation THT Abstracts 2025

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Presenter: Jason Feinman

February 11, 2025

Presentation THT Abstracts 2025

Characteristics and Outcomes of Patients Transferred to a “Hub” Center for Cardiogenic Shock

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT Abstracts 2025

Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database

Presenter: Thitiphan Srikulmontri

February 11, 2025

Presentation THT Abstracts 2025

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Presenter: Phuuwadith Wattanachayakul

February 11, 2025

Presentation THT Abstracts 2025

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

Presenter: Emmanuel Otabor

February 11, 2025

Presentation THT Abstracts 2024

Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients?

Presenter: Julia Baranowska

March 05, 2024

Advertisement

The Diabetes Paradox: Outcomes in Heart Failure Patients With Diabetes

Impact of LV Unloading Strategy on Clinical Outcomes of Patients Supported With VA-ECMO from the Cardiogenic Shock Working Group

Trend and Impact of Right Heart Catheterization on Outcomes in Cardiogenic Shock

Comparative Outcomes of Temporary Mechanical Circulatory Support in Acute Myocardial Infarction-Related Cardiogenic Shock

Beta-Blocker Therapy and Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction After Heart Transplantation: Real-World Evidence

Heart Transplantation Outcomes in Older Adults: A Single-Center Experience

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Impact of Sitagliptin on Long-Term Outcomes in Heart Failure With Reduced Ejection Fraction in Type 2 Diabetes Patients: A Retrospective Cohort Study

Outcomes of Sodium-Glucose Cotransporter 2 Inhibitor Use in Cardiac Sarcoidosis Cardiomyopathy

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Sex Differences in the Utilization and Outcomes of Advanced MCS Devices in Cardiogenic Shock

Impact of Psychological Comorbidities on Clinical Outcomes in Heart Failure With Reduced Ejection Fraction (HFrEF)

TRISCEND II Trial: Right Heart Failure Outcomes in Patients With Severe Tricuspid Regurgitation at One Year

Comparative Outcomes of Veno-Arterial ECMO (VA-ECMO) vs. IMPELLA vs. Combining VA-ECMO With IMPELLA (ECPELLA) in Cardiogenic Shock

Association of Temporary Mechanical Circulatory Support With Allosensitization and Cardiac Transplant Outcomes

Characteristics and Outcomes of Patients Transferred to a “Hub” Center for Cardiogenic Shock

Assessing Long-Term Outcomes of Tirzepatide and Semaglutide in Heart Failure With Preserved Ejection Fraction: A Retrospective Cohort Analysis From TrinetX Database

Clinical Outcomes Among Patients With HFpEF and Peripheral Arterial Disease Undergoing Revascularization

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content